BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Dong X, Wang Y, Wang L, Han G, Jin L, Fan Y, Xu G, Yuan D, Zheng J, Guo X, Gao P. Overexpression of LncRNA BM466146 Predicts Better Prognosis of Breast Cancer. Front Oncol 2020;10:628757. [PMID: 33585256 DOI: 10.3389/fonc.2020.628757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang P, Ding J, Bian Y, Ma Z, Wang K, Li J. Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment. Med Oncol 2022;39:108. [PMID: 35578054 DOI: 10.1007/s12032-022-01680-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Feng S, Li H, Qiao J. Hierarchical multi-label classification based on LSTM network and Bayesian decision theory for LncRNA function prediction. Sci Rep 2022;12:5819. [PMID: 35388048 DOI: 10.1038/s41598-022-09672-1] [Reference Citation Analysis]
3 Xu S, Xie J, Zhou Y, Liu H, Wang Y, Li Z. Integrated Analysis of RNA Binding Protein-Related lncRNA Prognostic Signature for Breast Cancer Patients. Genes 2022;13:345. [DOI: 10.3390/genes13020345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Shen S, Chen X, Hu X, Huo J, Luo L, Zhou X. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA. Cancer Med 2021. [PMID: 34378851 DOI: 10.1002/cam4.4189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]